ArticleScientific reports2026
Insights into the antibacterial, antifungal, and antiparasitic activities of functionalized ZnO quantum dots.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this article, we have synthesized mercaptoacetic acid (MAA), mercaptopropionic acid (MPA), ethylene glycol (EG), and citric acid (CA) functionalized ZnO quantum dots (QDs) and the role of these QDs as antibacterial, antifungal, and antiparasitic assays is investigated. In the antibacterial trial, it is observed that the zone of inhibition (ZOI) varies with the functionalized ligand of the ZnO QDs. The antifungal activity of these ligand-coated QDs using potato dextrose agar (PDA) containing petri plates has been inspected. The maximum antifungal activity of 78.3 % is explored against Aspergillus niger by MAA functionalized ZnO QDs at an optimized concentration of 2 mg/mL. During antiparasitic measurements, the promastigote and amastigote cell cultures of L. tropica are studied in this probe, by means of the MTT assay for ligand-coated these functionalized ZnO QDs at 20 µg/mL. The parasite's promastigote and amastigote forms each have a highest death rate of 70.31±1.16 and 68.17±0.12, respectively, which is achieved through MAA functionalized ZnO QDs, while at the same time, the minimum activity of 34.44±0.12 and 32.24±0.33 is measured in the case of CA functionalized ZnO QDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.